The Scientist

» drug development and microbiology

Most Recent

image: Imagining a “World Without Microbes”

Imagining a “World Without Microbes”

By | December 18, 2014

Eradication of microbial disease likely accompanied by poor quality of life for remaining species


image: Microbes Could Help Solve Sex Crimes

Microbes Could Help Solve Sex Crimes

By | December 17, 2014

Microbial species found in pubic hair samples could help track down criminals.


image: Layoffs, Restructuring at GSK

Layoffs, Restructuring at GSK

By | December 4, 2014

GlaxoSmithKline is eliminating 900 US jobs—most in R&D.


image: Gene Jumped to All Three Domains of Life

Gene Jumped to All Three Domains of Life

By | December 1, 2014

By horizontal gene transfer, an antibacterial gene family has dispersed to a plant, an insect, several fungi, and an archaeon.

1 Comment

image: Cannabis Biotech

Cannabis Biotech

By | December 1, 2014

As medical marijuana businesses set up shop across the U.S., a handful of companies are taking the pharmaceutical route, guiding cannabis-derived drugs through clinical trials.


image: Desktop Human

Desktop Human

By | December 1, 2014

Meet the researchers behind ATHENA, the project that aims to create a system of linked model human organs that may revolutionize drug development.


image: Homo Minutus

Homo Minutus

By | December 1, 2014

A miniature platform with multiple organ-on-a-chip constructs aims to speed up drug discovery—and create better transplants for patients.

1 Comment

image: Microflora for Hire

Microflora for Hire

By | December 1, 2014

The guts of cows and termites harbor microbes that are renowned complex-carbohydrate digesters, but the human gastrointestinal tract has flora that just might measure up.


image: Polymerase Pieces

Polymerase Pieces

By | December 1, 2014

Researchers discover a new subunit of a bacterial RNA polymerase—as well as hints of its potential role in defending against viruses.


image: Study: Drug Development Costs $2.6B

Study: Drug Development Costs $2.6B

By | November 24, 2014

A new estimate finds the pricetag for taking a drug through the approval process has steadily risen over the past few decades.


Popular Now

  1. Inside a Lab Mouse’s High-Fat Diet
  2. Battling the Bulge
    Bio Business Battling the Bulge

    Weight-loss drugs that target newly characterized obesity-related receptors and pathways could finally offer truly effective fat control.

  3. How Gastric Bypass Can Kill Sugar Cravings
  4. Birth of the Skin Microbiome
    Daily News Birth of the Skin Microbiome

    The immune system tolerates the colonization of commensal bacteria on the skin with the aid of regulatory T cells during the first few weeks of life, a mouse study shows.

Life Technologies